Microbot Medical Inc. MBOT
We take great care to ensure that the data presented and summarized in this overview for Microbot Medical Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MBOT
Top Purchases
Top Sells
About MBOT
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Insider Transactions at MBOT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 19
2020
|
Yoseph Bornstein Director |
SELL
Open market or private sale
|
Indirect |
4,881
-1.98%
|
$34,167
$7.94 P/Share
|
|
Oct 05
2020
|
Yoseph Bornstein Director |
SELL
Open market or private sale
|
Indirect |
40,000
-4.85%
|
$280,000
$7.77 P/Share
|